Fig. 3From: Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplantFailure-free survival of two cohorts: HID, 3-year FFS of 85.0% ± 3.9%; MRD, 3-year FFS of 89.8% ± 3.7% (P = 0.413)Back to article page